Lineage Cell Therapeutics, Inc. Balance Sheet
LCTX|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$113M
FY2025
Cash
$41M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$45M
FY2025
Lineage Cell Therapeutics, Inc. had $113M in total assets and $45M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40.8M | $45.8M | $35.4M | $11.4M | $55.7M | $9.5M | $23.6M | $36.8M | $22.1M | $29.5M | $5.5M | $4.3M | $22.2M | $33.3M | $12.2M |
| Accounts Receivable | $891.0K | $638.0K | $745.0K | $200.0K | $50.6M | - | - | $51.0K | $139.0K | $344.0K | $754.0K | $549.3K | $575.9K | $404.0K | - |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | $266.0K | $178.7K | $55.3K | $51.2K |
| Current Assets | $59.2M | $51.0M | $38.4M | $60.0M | $111.5M | $44.0M | $57.5M | $36.4M | $42.6M | $25.6M | $47.2M | $32.4M | $7.9M | $7.2M | $25.0M |
| PP&E (Net) | $2.6M | $2.3M | $2.2M | $5.7M | $4.9M | $5.6M | $8.2M | $5.8M | $5.5M | $5.5M | $7.5M | $2.9M | $3.0M | $1.3M | $1.3M |
| Goodwill | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | - | - | - | - | - | - | - | - |
| Total Assets | $112.6M | $113.2M | $101.0M | $123.7M | $174.5M | $107.9M | $125.5M | $101.7M | $173.2M | $142.6M | $94.7M | $74.9M | $57.7M | $29.7M | $45.8M |
| Current Liabilities | $11.4M | $14.0M | $18.0M | $19.0M | $47.1M | $7.8M | $6.5M | $6.8M | $6.9M | $8.8M | $12.5M | $7.1M | $7.0M | $4.4M | $3.1M |
| Shareholders' Equity | $44.5M | $78.4M | $63.4M | $73.3M | $92.2M | $96.2M | $93.8M | $93.8M | $162.6M | $117.9M | $26.9M | $36.5M | $14.8M | $9.6M | $28.6M |